Belvedere Trading LLC Bio Atla, Inc. Transaction History

Belvedere Trading LLC

$77.2 Billion
Q1 2024

A detailed history of Belvedere Trading LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 11,734 shares of BCAB stock, worth $16,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,734

Holding current value

$16,075

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 09, 2024	BUY	$1.88 - $3.46 $22,059 - $40,599	11,734 New	11,734 $40,000
Q3 2023 Oct 27, 2023	BUY	$1.7 - $3.07 $16,435 - $29,680	9,668 New	9,668 $16,000

Others Institutions Holding BCAB

# of Institutions

Shares Held

24.8M

Call Options Held

140K

Put Options Held

4.6K

Soleus Capital Management, L.P. Greenwich, CT

4.07M
Shares

$5.57 Million
1.14% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$3.81 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$2.88 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.91M
Shares

$2.62 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

1.47M
Shares

$2.02 Million
0.62% of portfolio

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $49.7M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Account